NasdaqCM - Nasdaq Real Time Price USD
CNS Pharmaceuticals, Inc. (CNSP)
1.1900
-0.1700
(-12.50%)
As of 12:38:00 PM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| CLIMACO JOHN M Chief Executive Officer | Purchase | Feb 1, 2024 | 215,676 |
| DOWNS CHRISTOPHER Chief Financial Officer | Purchase | Feb 1, 2024 | 103,438 |
| EVANS CARL ANTHONY Director | Purchase | Feb 1, 2024 | 33,458 |
| GUMULKA JERZY Director | Purchase | Feb 1, 2024 | 43,006 |
| KEYES JEFFRY R Director | Stock Award(Grant) | Mar 7, 2022 | 11,100 |
| PRIEBE WALDEMAR PH.D. Beneficial Owner of more than 10% of a Class of Security | Sale | Mar 28, 2023 | -- |
Related Tickers
HCWB HCW Biologics Inc.
9.52
-5.30%
XLO Xilio Therapeutics, Inc.
0.9609
-16.44%
TOVX Theriva Biologics, Inc.
0.5879
+4.98%
CTMX CytomX Therapeutics, Inc.
2.1550
-13.80%
HEPA Hepion Pharmaceuticals, Inc.
0.3180
0.00%
KTTA Pasithea Therapeutics Corp.
0.9462
+10.02%
PLRZ Polyrizon Ltd.
0.0132
-53.68%
ZVSA ZyVersa Therapeutics, Inc.
0.5014
-3.20%
ALZN Alzamend Neuro, Inc.
3.9500
-5.52%
CRVS Corvus Pharmaceuticals, Inc.
3.6200
-6.94%